Insider · CIK 0001263230

PEREZ ROBERT J

Reports to the SEC for 12 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001263230

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.2K sh	—	—	15,200
2025-06-17	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	10,925
2024-11-07	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.8K sh	—	—	29,756
2023-05-22	VIRVir Biotechnology, Inc.A Award	Director	AAward	+6,027 sh	—	—	15,806
2023-05-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,054
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.7K sh	—	—	0
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+13.7K sh	—	—	13,667
2022-10-26	Third Harmonic Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+13.7K sh	—	—	13,667
2022-05-23	VIRVir Biotechnology, Inc.A Award	Director	AAward	+6,405 sh	—	—	9,779
2022-05-23	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,810
2021-05-21	VIRVir Biotechnology, Inc.A Award	Director	AAward	+3,374 sh	—	—	3,374
2021-05-21	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,748 sh	—	—	6,748
2020-05-21	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.9K sh	—	—	28,888
2020-05-21	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24.6K sh	—	—	24,567
2019-12-17	Spark Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2,500 sh	$114.50	−$286K	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2019-10-10	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.2K sh	—	—	22,222
2019-06-26	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2019-06-14	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,131 sh	$1.67	+$11.9K	7,131
2019-05-30	Spark Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	—	—	2,500
2019-05-30	Spark Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	0
2019-05-16	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+8,116 sh	—	—	29,229
2019-05-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+17.3K sh	—	—	17,326
2019-04-01	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,369 sh	$2.72	+$11.9K	4,369
2019-01-24	LRMRLarimar Therapeutics, Inc.A Award	Director	AAward	+4,423 sh	$4.38	+$19.4K	5,322
2019-01-24	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,717 sh	—	—	5,717
2019-01-03	Spark Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	—	—	1,000
2019-01-03	Spark Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	2,000
2019-01-02	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,397 sh	$2.70	+$11.9K	4,397
2018-10-01	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,910 sh	$6.22	+$11.9K	1,910
2018-07-26	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,361 sh	$8.72	+$11.9K	1,361
2018-06-07	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+3,578 sh	—	—	21,113
2018-06-07	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,543 sh	—	—	7,543
2018-06-06	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-05-30	Spark Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2018-05-30	Spark Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,500 sh	—	—	1,500
2018-01-03	Spark Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2018-01-03	Spark Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+3,000 sh	—	—	3,000
2018-01-03	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,421 sh	—	—	9,421
2017-07-26	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-06-21	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2017-05-18	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+4,545 sh	—	—	17,535
2017-05-18	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+10.1K sh	—	—	10,110
2017-02-13	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.3K sh	—	—	13,289
2016-06-30	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2016-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2016-06-08	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jun 104
PEREZ ROBERT J0001193125-26-266147
SEC(opens sec.gov)
Jun 184
PEREZ ROBERT J0000950170-25-087900
SEC(opens sec.gov)
Nov 74
PEREZ ROBERT J0000950170-24-123610
SEC(opens sec.gov)
May 244
PEREZ ROBERT J0001209191-23-031850
SEC(opens sec.gov)
Mar 84
PEREZ ROBERT J0001209191-23-017244
SEC(opens sec.gov)
Oct 274
PEREZ ROBERT J0001209191-22-054730
SEC(opens sec.gov)
May 254
PEREZ ROBERT J0001209191-22-031951
SEC(opens sec.gov)
May 254
PEREZ ROBERT J0001209191-21-035713
SEC(opens sec.gov)
Oct 134/A
PEREZ ROBERT J0001209191-20-054739
SEC(opens sec.gov)
May 264
PEREZ ROBERT J0001209191-20-032060
SEC(opens sec.gov)
Dec 174
PEREZ ROBERT J0000899243-19-029446
SEC(opens sec.gov)
Oct 104
PEREZ ROBERT J0001209191-19-052974
SEC(opens sec.gov)
Jun 274
PEREZ ROBERT J0000899243-19-018481
SEC(opens sec.gov)

Companies

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110